We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You can change your cookie settings at any time.
A weekly report covering adverse reactions to approved COVID-19 vaccines
This report covers the period 9 December 2020 to 5 May 2021. Summary At…
Information for healthcare professionals and the public about the Pfizer/BioNTech vaccine.
Regulation 174 Information for UK healthcare professionals This medicinal…
Regulation 174 Information for UK recipients COVID-19 mRNA Vaccine…
Vaccine BNT162b2 – Conditions of authorisation under Regulation 174 – 2…
Summary of the Public Assessment Report Authorisation for Temporary…
Information for healthcare professionals and the public about the COVID-19 Vaccine AstraZeneca.
Regulation 174 Information for UK recipients Package leaflet: Information…
Amended on 23 February 2021 General This temporary Authorisation under…
The home of Medicines and Healthcare products Regulatory Agency on GOV.UK. The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK.
The benefits of vaccination continue to outweigh any risks but the MHRA advises careful consideration be given to people who are at higher risk of specific types of blood clots because of their medical condition.
Find alerts and recalls issued by MHRA
Statement from Dr June Raine, MHRA Chief Executive, following the Joint Committee on Vaccination and Immunisation's new advice
Information for healthcare professionals and the public about the COVID-19 Vaccine Moderna
We are producing guidance and information for industry, healthcare professionals and patients covering the coronavirus (COVID-19) outbreak.
What you need to do to place a medical device on the Great Britain, Northern Ireland and European Union (EU) markets.
Becton Dickinson (BD) is recalling specific lots of BD Venflon Pro Safety (VPS) Needle Protected IV Cannulae after identifying an increase in reports of leakage from the injection port.
Search for information about medicines including patient information leaflets (PILs), details on how the medicine can be used (SmPCs) and scientific reports (PARs).
Lupin Healthcare (UK) Limited has informed us of a discrepancy with the product packaging for several batches of Syonell 250mg Gastro-Resistant Tablets and Syonell 500mg Gastro-Resistant Tablets. This discrepancy relates to …
Summary list of field safety notices (FSNs) from medical device manufacturers from 3 to 7 May 2021
Guidance for industry and organisations to follow from 1 January 2021.
Summary list of field safety notices (FSNs) from medical device manufacturers from 26 April to 30 April 2021
Addition of a polyethylene glycol (PEG)-based laxative to a liquid that has been thickened with a starch-based thickener may counteract the thickening action, placing patients with dysphagia at a greater risk of aspiration.
How to register your medical devices with the Medicines and Healthcare products Regulatory Agency (MHRA) for the markets in Great Britain and Northern Ireland
UK medicines regulator issues its first authorisation under Project Orbis for Osimertinib (Tagrisso), a post-surgery treatment for lung cancer.
Find drug safety updates issued by MHRA
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.